Suspension of trading
Sector Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 01/10/24 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 30/09/24 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -59.75% | -96.67% | -98.57% | 12.59M | |
| +3.08% | +9.20% | +12.43% | +11.45% | +4.61% | -0.42% | +5.47% | -14.21% | +249.01% | 47.18B | |
| +0.12% | +10.45% | +14.56% | +90.10% | +135.42% | +408.29% | +598.88% | +461.24% | - | 39.82B | |
| +5.17% | +9.47% | +8.77% | +17.87% | -9.85% | +24.96% | -8.08% | -17.78% | +203.92% | 32.25B | |
| +2.02% | +4.91% | +3.95% | -5.74% | -4.30% | +18.59% | +60.76% | -16.85% | +880.90% | 31.68B | |
| +0.69% | +8.72% | -5.02% | -7.09% | +1.23% | +14.80% | +30.86% | -20.95% | +158.40% | 24.59B | |
| +0.40% | +12.51% | +22.38% | - | - | - | - | - | - | 16.57B | |
| +2.64% | +6.00% | +20.40% | +11.05% | -3.22% | +69.30% | +127.40% | +204.74% | - | 15.12B | |
| -0.15% | +4.94% | +9.61% | +9.26% | +9.71% | +13.27% | +17.71% | -28.98% | +105.22% | 13.69B | |
| -0.13% | +3.49% | +5.05% | +5.40% | +0.10% | +98.27% | +92.77% | +97.73% | +224.28% | 13.1B | |
| +0.77% | +10.67% | +26.82% | +57.11% | -3.93% | +17.58% | -27.97% | -18.90% | +147.81% | 13.31B | |
| +0.50% | +20.59% | +39.79% | +32.76% | +20.73% | +36.33% | -12.50% | -37.43% | +153.03% | 11.01B | |
| +1.01% | +13.35% | +25.83% | +30.98% | +14.84% | +48.37% | +9.79% | -38.52% | +175.02% | 10.92B | |
| +6.34% | +18.60% | +16.67% | +30.98% | +4.32% | +3.63% | - | - | - | 10.4B | |
| +0.03% | +0.06% | +67.43% | +57.61% | +75.90% | +199.98% | - | - | - | 9.95B | |
| -4.54% | +3.45% | -4.64% | +0.10% | +8.43% | +640.33% | +1,752.75% | +15.67% | - | 9.33B | |
| -0.41% | +14.35% | +45.53% | +34.46% | +46.77% | +156.98% | +384.31% | +103.67% | - | 9.43B | |
| -1.29% | +2.52% | +22.36% | +47.56% | +84.85% | +78.44% | +69.63% | +107.71% | +13.62% | 8.73B | |
| +0.14% | -.--% | -.--% | -.--% | -.--% | +1.00% | +104.84% | +47.18% | +539.31% | 8.38B | |
| +0.08% | +1.03% | +8.15% | -3.10% | -17.34% | -22.89% | -22.37% | -28.50% | +52.75% | 8.09B | |
| Average | +0.78% | +9.74% | +17.00% | +22.15% | +19.38% | +95.09% | +183.79% | +42.30% | +215.75% | 16.68B | |
| Weighted average by Cap. | +1.37% | +9.31% | +14.68% | +24.55% | +23.75% | +99.89% | +171.24% | +71.45% | +292.15% |
- Stock Market
- Stocks
- EIGR Stock
- Sector Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
